ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 131

Prevalence and Antecedents Of Fibromyalgia In Elderly Women

Brian T. Walitt1 and Frederick Wolfe2, 1Rheumatology, Washington Hospital Center, Washington, DC, 2National Data Bank for Rheumatic Diseases, Wichita, KS

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Elderly and fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Fibromyalgia, Soft Tissue Disorders and Pain I

Session Type: Abstract Submissions (ACR)

Prevalence and Antecedents of Fibromyalgia in elderly women

Background/Purpose: Although epidemiological studies demonstrate that fibromyalgia (FM) prevalence increases with age, there have been no large-scale studies of FM in the elderly. In the clinic, elderly subjects usually receive treatment for common problems like diabetes, hypertension, back pain syndromes and other chronic illnesses; and the presence of FM is rarely recognized. In 2013 we performed a pilot study to estimate FM prevalence in the elderly by studying 882 women participants of the Women’s Health Initiative (WHI). Because the WHI study is longitudinal, we used prior data to investigate factors that predicted subsequent FM development.

Methods: In 2013, we administered the 2010 modified American College of Rheumatology (ACR) survey criteria questionnaire to 882 randomly selected WHI participants. We utilized a wide range of questionnaire data that had been collected at WHI enrollment 16 years previously, including a range of questions from the SF-36, CESD depression scale, symptoms scales, and other questionnaires. We used logistic regression and baseline variables to predict current FM.

Results: In 2013, the age of participants was 78.4 (SD 6.0) and they had been followed by the WHI for 16.4 years. The (2013) prevalence of fibromyalgia was 6.6% (95% CI 4.9-8.2). The average questionnaire scores in the population were: widespread pain index (WPI, 2.8 (2.8)), the symptom severity scale (SS, 2.9 (2.3), and the polysymptomatic distress score (PSD – sum of WPI and SS) 5.7 (4.3). To identify predictors of FM at initiation, we first excluded possible FM cases (15%) at study onset from further analysis if they reported moderate or severe body pain during the past 4 weeks. Of the remaining 746 subjects, the 2013 FM prevalence was 4.7% (3.1-6.2). In univariate analyses the following variables predicted FM 16 years later: social function, physical function, body pain, pain interference, general health, energy/fatigue, sadness in last two weeks, upset stomach, depression, headaches, low back pain, neck pain, diarrhea, aches and pain, constipation, and tiredness. In multivariate analyses, the following variables were included after backward stepwise regression filtering: constipation, pain severity, general health, energy/fatigue, neck pain, pain interference, and aches and pains. The area under the ROC for the final logistic model was 0.85.

Conclusion: Fibromyalgia (by criteria) was common in WHI participants as they approached 80 years of age. FM appeared to develop primarily in those baseline pain, aching, fatigue, impaired general health, and GI symptoms. Psychological factors did not seem to be important predictors.

 

Table 1. Multivariable baseline predictors of fibromyalgia

Variable

Odds Ratio

P-Value

95% CI

Constipation (Y/N)

2.92

0.005

1.37, 6.25

Neck pain (Y/N)

3.57

0.002

1.59, 8.04

Pain interference (Y/N)

3.09

0.088

0.85, 11.30

SF-36 General Health

0.97

0.052

0.95, 1.00

SF-36 Energy/fatigue

0.98

0.019

0.96 1.00

SF-36 pain

1.05

0.042

1.00, 1.00

Aches and pains

 

 

 

     Aches and Pains – Mild

3.44

0.120

0.72, 16.39

     Aches and Pains – Moderate or >

13.22

0.004

2.24, 77.99

 


Disclosure:

B. T. Walitt,
None;

F. Wolfe,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-and-antecedents-of-fibromyalgia-in-elderly-women/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology